These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 25683917)

  • 21. β-adrenergic signaling inhibits Gq-dependent protein kinase D activation by preventing protein kinase D translocation.
    Nichols CB; Chang CW; Ferrero M; Wood BM; Stein ML; Ferguson AJ; Ha D; Rigor RR; Bossuyt S; Bossuyt J
    Circ Res; 2014 Apr; 114(9):1398-409. PubMed ID: 24643961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A long lasting β1 adrenergic receptor stimulation of cAMP/protein kinase A (PKA) signal in cardiac myocytes.
    Fu Q; Kim S; Soto D; De Arcangelis V; DiPilato L; Liu S; Xu B; Shi Q; Zhang J; Xiang YK
    J Biol Chem; 2014 May; 289(21):14771-81. PubMed ID: 24713698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterologous desensitization of cardiac β-adrenergic signal via hormone-induced βAR/arrestin/PDE4 complexes.
    Shi Q; Li M; Mika D; Fu Q; Kim S; Phan J; Shen A; Vandecasteele G; Xiang YK
    Cardiovasc Res; 2017 May; 113(6):656-670. PubMed ID: 28339772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
    Kwak HJ; Park KM; Choi HE; Chung KS; Lim HJ; Park HY
    Cell Signal; 2008 May; 20(5):803-14. PubMed ID: 18276108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy.
    Appert-Collin A; Cotecchia S; Nenniger-Tosato M; Pedrazzini T; Diviani D
    Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10140-5. PubMed ID: 17537920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of cytoplasmic and nuclear protein kinase A by phosphodiesterases and phosphatases in cardiac myocytes.
    Haj Slimane Z; Bedioune I; Lechêne P; Varin A; Lefebvre F; Mateo P; Domergue-Dupont V; Dewenter M; Richter W; Conti M; El-Armouche A; Zhang J; Fischmeister R; Vandecasteele G
    Cardiovasc Res; 2014 Apr; 102(1):97-106. PubMed ID: 24550350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex differences in SR Ca(2+) release in murine ventricular myocytes are regulated by the cAMP/PKA pathway.
    Parks RJ; Ray G; Bienvenu LA; Rose RA; Howlett SE
    J Mol Cell Cardiol; 2014 Oct; 75():162-73. PubMed ID: 25066697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.
    Pérez López I; Cariolato L; Maric D; Gillet L; Abriel H; Diviani D
    Mol Cell Biol; 2013 Aug; 33(15):2903-17. PubMed ID: 23716597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein Kinase A (PKA) Phosphorylation of Shp2 Protein Inhibits Its Phosphatase Activity and Modulates Ligand Specificity.
    Burmeister BT; Wang L; Gold MG; Skidgel RA; O'Bryan JP; Carnegie GK
    J Biol Chem; 2015 May; 290(19):12058-67. PubMed ID: 25802336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compartmentalized cyclic nucleotides have opposing effects on regulation of hypertrophic phospholipase Cε signaling in cardiac myocytes.
    Nash CA; Brown LM; Malik S; Cheng X; Smrcka AV
    J Mol Cell Cardiol; 2018 Aug; 121():51-59. PubMed ID: 29885334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners.
    Houslay KF; Christian F; MacLeod R; Adams DR; Houslay MD; Baillie GS
    Biochem J; 2017 Feb; 474(4):597-609. PubMed ID: 27993970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3beta.
    El Jamali A; Freund C; Rechner C; Scheidereit C; Dietz R; Bergmann MW
    FASEB J; 2004 Jul; 18(10):1096-8. PubMed ID: 15155564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway.
    Carnegie GK; Soughayer J; Smith FD; Pedroja BS; Zhang F; Diviani D; Bristow MR; Kunkel MT; Newton AC; Langeberg LK; Scott JD
    Mol Cell; 2008 Oct; 32(2):169-79. PubMed ID: 18951085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
    Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
    Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AMPK Attenuation of β-Adrenergic Receptor-Induced Cardiac Injury via Phosphorylation of β-Arrestin-1-ser330.
    Zhao M; Cao N; Gu H; Xu J; Xu W; Zhang D; Wei TW; Wang K; Guo R; Cui H; Wang X; Guo X; Li Z; He K; Li Z; Zhang Y; Shyy JY; Dong E; Xiao H
    Circ Res; 2024 Aug; 135(6):651-667. PubMed ID: 39082138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
    Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
    Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid effects of aldosterone in primary cultures of cardiomyocytes - do they suggest the existence of a membrane-bound receptor?
    Araujo CM; Hermidorff MM; Amancio Gde C; Lemos Dda S; Silva ME; de Assis LV; Isoldi MC
    J Recept Signal Transduct Res; 2016 Oct; 36(5):435-44. PubMed ID: 27305962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes.
    De Arcangelis V; Liu R; Soto D; Xiang Y
    J Biol Chem; 2009 Dec; 284(49):33824-32. PubMed ID: 19801680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis.
    Kaname T; Ki CS; Niikawa N; Baillie GS; Day JP; Yamamura K; Ohta T; Nishimura G; Mastuura N; Kim OH; Sohn YB; Kim HW; Cho SY; Ko AR; Lee JY; Kim HW; Ryu SH; Rhee H; Yang KS; Joo K; Lee J; Kim CH; Cho KH; Kim D; Yanagi K; Naritomi K; Yoshiura K; Kondoh T; Nii E; Tonoki H; Houslay MD; Jin DK
    Cell Signal; 2014 Nov; 26(11):2446-59. PubMed ID: 25064455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure.
    Ding B; Abe JI; Wei H; Huang Q; Walsh RA; Molina CA; Zhao A; Sadoshima J; Blaxall BC; Berk BC; Yan C
    Circulation; 2005 May; 111(19):2469-2476. PubMed ID: 15867171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.